NEW ZEALAND GAZETTE, No. 71

10 APRIL 2008

the free acid, base, alcohol or element unless specifically
stated otherwise.

Schedule 1

Prescription Medicines

Alglucosidase alfa

Aspirin; for injection; when combined with caffeine,
paracetamol or salicylamide

Boron including borax and boric acid; except for internal
use in medicines containing 6 milligrams or less per
recommended daily dose; except in dermal medicines for
use other than paediatric use containing 0.35% or less;
except when present as an excipient

Daptomycin

Furosemide

Galsulfase

Ixabepilone

Laropiprant

Levomepromazine

Nicotinic acid except nicotinamide; in medicines containing
more than 250 milligrams per dose form

Paricalcitol

Polysulfated glycosaminoglycans; for injection except in
intraocular viscoelastic products

Raltegravir

Ranibizumab

*Ranitidine; except when specified elsewhere in this
Schedule; except in medicines containing 150 milligrams
or less per dose unit which have received the consent of
the Minister or the Director-General to their distribution
as general sale medicines and which are sold in the
manufacturer’s original pack containing not more than
7 days’ supply

Sitaxentan

*Zinc; for internal use in medicines containing more than
25 milligrams per recommended daily dose; except for
internal use in medicines containing 50 milligrams or
less and more than 25 milligrams per recommended
daily dose in packs which have received the consent of
the Minister or the Director-General to their distribution
as general sale medicines and which are sold in the
manufacturer’s original pack and when labelled with a
statement that the product may be dangerous if taken in
large amounts or for long periods; except in parenteral
nutrition replacement preparations

Schedule 2

Restricted Medicines

Aspirin; in slow release forms; in enteric coated forms
containing more than 300 milligrams per dose form;
except when specified elsewhere in this Schedule

Nicotinic acid except nicotinamide; in medicines containing
250 milligrams or less but more than 100 milligrams per
dose form

Schedule 3

Pharmacy-only Medicines

Antazoline; for ophthalmic use except when sold in practice
by a registered optometrist

Dibromopropamidine; for ophthalmic use except when sold
in practice by a registered optometrist

Levocabastine; for nasal use; for ophthalmic use except
when sold in practice by a registered optometrist

Lodoxamide; for ophthalmic use except when sold in
practice by a registered optometrist

Naphazoline; except for ophthalmic use when sold in
practice by a registered optometrist

Oxymetazoline; except for nasal use when sold at an airport;
except for ophthalmic use when sold in practice by a
registered optometrist

Pheniramine; for ophthalmic use except when sold in
practice by a registered optometrist; for oral use
in medicines for adults and children over two years of
age when combined in the same container with one
or more other therapeutically active substances either
when in the bedtime dose of a day-night pack
containing pheniramine or when at least one of the other
therapeutically active substances is a sympathomimetic
decongestant

Propamidine; for ophthalmic use except when sold in
practice by a registered optometrist

*Ranitidine; in medicines which have received the
consent of the Minister or the Director-General to their
distribution as pharmacy-only medicines and which
are sold in the manufacturer’s original pack containing
not more than 14 days’ supply; except in medicines
containing not more than 150 milligrams per dose unit
which have received the consent of the Minister or the
Director-General to their distribution as general sale
medicines and which are sold in the manufacturer’s
original pack containing not more than 7 days’ supply

Pyrethrins; in medicines containing more than 10%

Sodium cromoglycate; for nasal use; for ophthalmic use
except when sold in practice by a registered optometrist

Tetrahydrazoline; except for ophthalmic use when sold in
practice by a registered optometrist

Xylometazoline; except for nasal use when sold at an
airport; except for ophthalmic use when sold in practice
by a registered optometrist

Medicines for General Sale

Please note that the following medicines are no longer
classified as prescription medicines, restricted medicines or
pharmacy-only medicines. As such, they are now available
for general sale.

Aspirin; except when specified in the First Schedule to the
Medicines Regulations 1984

Boron including borax and boric acid; in medicines for
internal use containing 6 milligrams or less per
recommended daily dose; for dermal use other than
paediatric use in medicines containing 0.35% or less;
when present as an excipient

Nicotinamide

Nicotinic acid; in medicines containing 100 milligrams or
less per dose form

Octocog alfa

Perflutren

Polysulfated glycosaminoglycans; except in injections other
than intraocular viscoelastic products

Pyrethrins; in medicines containing 10% or less

*Ranitidine; in medicines containing not more than 150
milligrams per dose unit which have received the
consent of the Minister or the Director-General to their
distribution as general sale medicines and which are
sold in the manufacturer’s original pack containing not
more than 7 days’ supply

*Zinc; for external use except in medicines containing more
than 5% of zinc chloride; for internal use in medicines
containing 25 milligrams or less per recommended
daily dose; for internal use in medicines containing
50 milligrams or less and more than 25 milligrams
per recommended daily dose in packs which have
received the consent of the Minister or the
Director-General to their distribution as general sale
medicines and which are sold in the manufacturer’s